Cargando…
P1697: CHARACTERISTICS, TREATMENT PATTERNS AND HEALTHCARE UTILIZATION OF PATIENTS WITH WARM AUTOIMMUNE HEMOLYTIC ANEMIA INITIATING FIRST LINE THERAPY OF ORAL CORTICOSTEROIDS WITH OR WITHOUT RITUXIMAB
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430377/ http://dx.doi.org/10.1097/01.HS9.0000973660.04294.a8 |
_version_ | 1785090948565303296 |
---|---|
author | Murakhovskaya, Irina Crivera, Concetta Leon, Ann Alemao, Evo Anupindi, Vamshi Ruthwik Dekoven, Mitch Divino, Victoria Lin, Iris Shu, Cathye Ebrahim, Tarek |
author_facet | Murakhovskaya, Irina Crivera, Concetta Leon, Ann Alemao, Evo Anupindi, Vamshi Ruthwik Dekoven, Mitch Divino, Victoria Lin, Iris Shu, Cathye Ebrahim, Tarek |
author_sort | Murakhovskaya, Irina |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10430377 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-104303772023-08-17 P1697: CHARACTERISTICS, TREATMENT PATTERNS AND HEALTHCARE UTILIZATION OF PATIENTS WITH WARM AUTOIMMUNE HEMOLYTIC ANEMIA INITIATING FIRST LINE THERAPY OF ORAL CORTICOSTEROIDS WITH OR WITHOUT RITUXIMAB Murakhovskaya, Irina Crivera, Concetta Leon, Ann Alemao, Evo Anupindi, Vamshi Ruthwik Dekoven, Mitch Divino, Victoria Lin, Iris Shu, Cathye Ebrahim, Tarek Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10430377/ http://dx.doi.org/10.1097/01.HS9.0000973660.04294.a8 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
spellingShingle | Posters Murakhovskaya, Irina Crivera, Concetta Leon, Ann Alemao, Evo Anupindi, Vamshi Ruthwik Dekoven, Mitch Divino, Victoria Lin, Iris Shu, Cathye Ebrahim, Tarek P1697: CHARACTERISTICS, TREATMENT PATTERNS AND HEALTHCARE UTILIZATION OF PATIENTS WITH WARM AUTOIMMUNE HEMOLYTIC ANEMIA INITIATING FIRST LINE THERAPY OF ORAL CORTICOSTEROIDS WITH OR WITHOUT RITUXIMAB |
title | P1697: CHARACTERISTICS, TREATMENT PATTERNS AND HEALTHCARE UTILIZATION OF PATIENTS WITH WARM AUTOIMMUNE HEMOLYTIC ANEMIA INITIATING FIRST LINE THERAPY OF ORAL CORTICOSTEROIDS WITH OR WITHOUT RITUXIMAB |
title_full | P1697: CHARACTERISTICS, TREATMENT PATTERNS AND HEALTHCARE UTILIZATION OF PATIENTS WITH WARM AUTOIMMUNE HEMOLYTIC ANEMIA INITIATING FIRST LINE THERAPY OF ORAL CORTICOSTEROIDS WITH OR WITHOUT RITUXIMAB |
title_fullStr | P1697: CHARACTERISTICS, TREATMENT PATTERNS AND HEALTHCARE UTILIZATION OF PATIENTS WITH WARM AUTOIMMUNE HEMOLYTIC ANEMIA INITIATING FIRST LINE THERAPY OF ORAL CORTICOSTEROIDS WITH OR WITHOUT RITUXIMAB |
title_full_unstemmed | P1697: CHARACTERISTICS, TREATMENT PATTERNS AND HEALTHCARE UTILIZATION OF PATIENTS WITH WARM AUTOIMMUNE HEMOLYTIC ANEMIA INITIATING FIRST LINE THERAPY OF ORAL CORTICOSTEROIDS WITH OR WITHOUT RITUXIMAB |
title_short | P1697: CHARACTERISTICS, TREATMENT PATTERNS AND HEALTHCARE UTILIZATION OF PATIENTS WITH WARM AUTOIMMUNE HEMOLYTIC ANEMIA INITIATING FIRST LINE THERAPY OF ORAL CORTICOSTEROIDS WITH OR WITHOUT RITUXIMAB |
title_sort | p1697: characteristics, treatment patterns and healthcare utilization of patients with warm autoimmune hemolytic anemia initiating first line therapy of oral corticosteroids with or without rituximab |
topic | Posters |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430377/ http://dx.doi.org/10.1097/01.HS9.0000973660.04294.a8 |
work_keys_str_mv | AT murakhovskayairina p1697characteristicstreatmentpatternsandhealthcareutilizationofpatientswithwarmautoimmunehemolyticanemiainitiatingfirstlinetherapyoforalcorticosteroidswithorwithoutrituximab AT criveraconcetta p1697characteristicstreatmentpatternsandhealthcareutilizationofpatientswithwarmautoimmunehemolyticanemiainitiatingfirstlinetherapyoforalcorticosteroidswithorwithoutrituximab AT leonann p1697characteristicstreatmentpatternsandhealthcareutilizationofpatientswithwarmautoimmunehemolyticanemiainitiatingfirstlinetherapyoforalcorticosteroidswithorwithoutrituximab AT alemaoevo p1697characteristicstreatmentpatternsandhealthcareutilizationofpatientswithwarmautoimmunehemolyticanemiainitiatingfirstlinetherapyoforalcorticosteroidswithorwithoutrituximab AT anupindivamshiruthwik p1697characteristicstreatmentpatternsandhealthcareutilizationofpatientswithwarmautoimmunehemolyticanemiainitiatingfirstlinetherapyoforalcorticosteroidswithorwithoutrituximab AT dekovenmitch p1697characteristicstreatmentpatternsandhealthcareutilizationofpatientswithwarmautoimmunehemolyticanemiainitiatingfirstlinetherapyoforalcorticosteroidswithorwithoutrituximab AT divinovictoria p1697characteristicstreatmentpatternsandhealthcareutilizationofpatientswithwarmautoimmunehemolyticanemiainitiatingfirstlinetherapyoforalcorticosteroidswithorwithoutrituximab AT liniris p1697characteristicstreatmentpatternsandhealthcareutilizationofpatientswithwarmautoimmunehemolyticanemiainitiatingfirstlinetherapyoforalcorticosteroidswithorwithoutrituximab AT shucathye p1697characteristicstreatmentpatternsandhealthcareutilizationofpatientswithwarmautoimmunehemolyticanemiainitiatingfirstlinetherapyoforalcorticosteroidswithorwithoutrituximab AT ebrahimtarek p1697characteristicstreatmentpatternsandhealthcareutilizationofpatientswithwarmautoimmunehemolyticanemiainitiatingfirstlinetherapyoforalcorticosteroidswithorwithoutrituximab |